ANDR yields 2000000.00% · PFE yields 6.20%● Live data
📍 ANDR pulled ahead of the other in Year 1
Combined, ANDR + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ANDR + PFE for your $10,000?
Andrea Electronics Corporation, together with its subsidiaries, designs, develops, and manufactures digital microphone products and noise reduction software that facilitate natural language and human/machine interfaces for the computer and business enterprise markets. It develops digital signal processing (DSP) products and technologies for the voice, speech, and natural language interface markets. The company's DSP microphone and audio noise reduction software products include DA-350 auto array microphone for far-field voice intelligibility and accuracy of automatic speech recognition in automotive and mass transit environments; DA-250 OEM array microphone, a small compact stereo array microphone and DSP circuit board platform; USB-SA array microphone, which offers a USB digital audio adapter to bypass a computer's standard integrated sound system; AudioCommander, a PC audio control panel; an audio software for Mac that offers an intuitive graphic user interface to control stereo array microphone beam forming and noise cancellation on the input and EQ filters; PureAudio Live Recorder, a digital voice and audio recording application; and PureAudio Plus Recorder, which provides bookmarks for navigation of recordings. Its products are used in various applications, including mass transit and automotive communication systems, automated teller machines, information kiosks, quick service restaurant automated ordering, Internet of Things, smart building entrance intercom systems, audio and video recordings, and video surveillance. It markets and sells its products through sales representatives to computer and kiosk OEMs and industrial system integrators in the United States and internationally. Andrea Electronics Corporation was incorporated in 1934 and is headquartered in Bohemia, New York.
Full ANDR Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.